GeneDx (WGS) Form 3: Director Thomas Fuchs Reports No Beneficial Ownership

Rhea-AI Filing Summary

Thomas Fuchs filed an initial Form 3 reporting his relationship to GeneDx Holdings Corp. (ticker: WGS) as a Director. The event date triggering the filing is 09/17/2025. The form states that no securities are beneficially owned by the reporting person. The filing is signed on behalf of Mr. Fuchs by Bridget Brown, Attorney-in-Fact dated 09/19/2025.

Positive

• Initial disclosure provided identifying reporting person, relationship to issuer, and event date
• Form filed and signed via authorized attorney-in-fact, meeting signature requirement

Negative

• No securities are beneficially owned by the reporting person as stated on the form

Insights

Corporate Governance Expert

TL;DR: Initial director disclosure shows no beneficial ownership reported.

The Form 3 documents a director-level relationship between Thomas Fuchs and GeneDx Holdings Corp. and explicitly states that the reporting person does not beneficially own any securities. As an initial Section 16 filing, it fulfills the statutory disclosure requirement by identifying the reporting person, address, relationship to the issuer, and the triggering event date. The filing is executed by an attorney-in-fact, which is common when principals use delegates for signature formalities.

Securities Compliance Analyst

TL;DR: The filing is a routine initial disclosure with no reported holdings.

The submission contains required identification details and certifies absence of beneficial ownership on Table I/II. From a compliance perspective, the form records the necessary data points: reporting person name and address, issuer and ticker, relationship (Director), event date (09/17/2025), and signature by an authorized attorney-in-fact dated 09/19/2025. There are no derivative or non-derivative positions listed.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Fuchs Thomas

(Last) (First) (Middle)

C/O GENEDX HOLDINGS CORP.

(Street)

STAMFORD CT 06902

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/17/2025

3. Issuer Name and Ticker or Trading Symbol
GeneDx Holdings Corp. [ WGS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Bridget Brown, Attorney-in-Fact	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 3 for GeneDx Holdings Corp. (WGS)?

Thomas Fuchs is the reporting person; the form was signed by Bridget Brown, Attorney-in-Fact on 09/19/2025.

What is Thomas Fuchs' relationship to GeneDx Holdings Corp. (WGS)?

The filing lists Thomas Fuchs as a Director of GeneDx Holdings Corp.

Does the Form 3 report any beneficial ownership of securities?

No. The form explicitly states: No securities are beneficially owned.

What is the event date that required this Form 3 filing?

The date of the event requiring the statement is 09/17/2025.

What ticker is used in the filing for GeneDx Holdings Corp.?

The filing lists the issuer as GeneDx Holdings Corp. with ticker shown as WGS.